Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Aspire Capital Partners
AddedFeb 19, 2024
UpdatedJun 28, 2026
Aspire Capital Partners

Aspire Capital Partners

Operating

Chicago-based Aspire Capital Fund LLC offers innovative investment structures, fueling growth in publicly traded companies.

Location
Chicago, IL, US
Founded
2010
Firm
Compare
Portfolio
Employees
Website

Aspire Capital Partners, based in Chicago, specializes in making direct investments in publicly traded companies across a broad range of industries. The firm typically engages in post-IPO equity rounds, providing innovative investment structures to companies with promising prospects that require additional capital for growth. Their investment sizes vary, with notable transactions including $20 million in Athersys and MediciNova, $25 million in Atossa Therapeutics, $15 million in Mobiquity Technologies, and $90 million in Solid Biosciences.

Aspire Capital Partners is managed by Aspire Capital Fund LLC and is known for its unique approach to fueling growth in publicly traded companies. The firm has a distinguished portfolio featuring companies like Athersys, Atossa Therapeutics, MediciNova, Mobiquity Technologies, and Solid Biosciences. Aspire Capital's investment philosophy centers on providing fair and efficient ways for companies to sell equity, ensuring they receive the necessary capital to expand and succeed in their respective markets.

Aspire Capital Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments6
Current Portfolio Count5
Total Portfolio Exits0

Top Investment Stages

Post Ipo Equity6 (100.0%)

Stage Mix

Post Ipo Equity 100%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Solid Biosciences logo

Solid Biosciences

Atossa Therapeutics logo

Atossa Therapeutics

Mobiquity Technologies logo

Mobiquity Technologies

MediciNova logo

MediciNova

Athersys logo

Athersys

Kips Bay Medical logo

Kips Bay Medical

Aspire Capital Partners - Classification

Also Known As
  • Aspire Capital Partners, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end